Genetic and chromosomal conditions

Angelman syndrome

Angelman syndrome is a genetic condition affecting development, communication, movement, and often sleep and seizures. Spoken language is usually substantially limited, but communication can develop through other methods. Support should recognize the child's interests and emotional needs rather than relying on stereotypes about personality.

Resource 067Published 3 October 20263-page PDF · 0.2 MB

For family education. This resource is not an individual diagnosis or treatment plan. Discuss concerns with an appropriately qualified professional.

What it means

Angelman syndrome is a genetic condition affecting development, communication, movement, and often sleep and seizures. Spoken language is usually substantially limited, but communication can develop through other methods. Support should recognize the child's interests and emotional needs rather than relying on stereotypes about personality.

Causes and risk factors

Angelman syndrome results from loss of effective function of the maternally inherited UBE3A gene in the brain. Several genetic mechanisms can cause this, including a chromosome deletion or gene change. The mechanism affects family counseling, so genetic results require specialist interpretation.

Signs and everyday impact

Developmental delay, limited spoken language, balance or movement difficulties, sleep disturbance, and seizures may occur. Some children have frequent smiling or laughter, but they also experience discomfort, frustration, and a full range of emotions. Communication needs and abilities vary and should be assessed directly.

Assessment and diagnosis

Clinical assessment reviews development, movement, seizures, and associated features. Genetic testing may include DNA methylation analysis and additional tests to identify the underlying mechanism. A negative initial test may require further specialist evaluation. Hearing, vision, nutrition, mobility, sleep, and communication assessments guide support.

Treatment and therapy

Care commonly includes seizure treatment, sleep management, physical and occupational therapy, and speech-language therapy focused on accessible communication. AAC can include signs, pictures, or devices and should be introduced according to need. Feeding, orthopedic, and other medical concerns receive targeted care. Developmental and educational supports should be coordinated across settings.

Support at home

Make AAC available throughout the day, including for saying no, asking for help, and expressing discomfort. Use predictable routines and supported choices. Follow movement and seizure plans, and track sleep patterns for the care team. Include enjoyable play and social activities without assuming laughter always means comfort.

When to seek help

Seek urgent assessment for prolonged or changed seizures, marked reduction in alertness, or inability to maintain hydration. New skill loss or major sleep and movement changes warrant medical review.

Questions for the care team

  • Which genetic mechanism caused the syndrome?
  • How can we provide reliable communication access?
  • What seizure, sleep, and mobility plans are needed?

Terms in plain language

  • UBE3A: a gene whose brain function is important in Angelman syndrome.
  • Methylation testing: a test that can identify certain chromosome-control patterns.
  • Ataxia: difficulty coordinating balance and movement.

Podcast preparation

Use this resource to prepare a later episode: define the topic, discuss causes and signs, explain assessment, describe treatment and home supports, then close with urgent signs and a next step.

Myth: a child who smiles often is always comfortable. Pain and distress still need attention.

Verify current clinical guidance and obtain clinical review before public recording.

Sources

  1. Angelman syndrome: MedlinePlus Genetics - https://medlineplus.gov/genetics/condition/angelman-syndrome/
  2. Angelman Syndrome - GeneReviews® - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK1144/
  3. Epilepsy and Seizures | National Institute of Neurological Disorders and Stroke - https://www.ninds.nih.gov/node/647

Sources accessed 3 October 2026.

Read the PDF

Use the viewer below or open the document in your browser. The PDF is a lighter web copy of the supplied guide, with its text and page layout preserved.

Show PDF viewer

PDF display depends on your browser. The web article above remains available on phones and devices without an embedded PDF viewer.